CN104447696B - The synthesis technique of lansoprazole - Google Patents

The synthesis technique of lansoprazole Download PDF

Info

Publication number
CN104447696B
CN104447696B CN201410663797.3A CN201410663797A CN104447696B CN 104447696 B CN104447696 B CN 104447696B CN 201410663797 A CN201410663797 A CN 201410663797A CN 104447696 B CN104447696 B CN 104447696B
Authority
CN
China
Prior art keywords
lansoprazole
adds
stirring
solid
cooled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410663797.3A
Other languages
Chinese (zh)
Other versions
CN104447696A (en
Inventor
谢应波
张庆
张华�
徐肖冰
张维燕
罗桂云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Titan Science & Technology Co Ltd
Original Assignee
Shanghai Titan Science & Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Titan Science & Technology Co Ltd filed Critical Shanghai Titan Science & Technology Co Ltd
Priority to CN201410663797.3A priority Critical patent/CN104447696B/en
Publication of CN104447696A publication Critical patent/CN104447696A/en
Application granted granted Critical
Publication of CN104447696B publication Critical patent/CN104447696B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention relates to the synthesis technique of a kind of lansoprazole, comprise the following steps: 2 chloromethyl 3 methyl 4 trifluoro ethoxy pyridine hydrochlorates and 2 mercaptobenzimidazoles are reacted in sodium carbonate methanol solution and post-treated off-white color solid;Aoxidize above-mentioned off-white color solid with the combination of cumyl hydroperoxide tetraisopropyl titanate, obtain the lansoprazole crude product being rendered as yellow solid through post processing;Lansoprazole crude product uses organic solvent to obtain lansoprazole fine work after being purified under the conditions of temperature 52 56 DEG C.Emphasis of the present invention is by the lansoprazole purifying crude condition improved and in optimization step three, the purification making final step, the yield concentrating, being dried link are brought up to 98% by the 90% of prior art, thus improve total recovery, the most industrial large-scale production and application.

Description

The synthesis technique of lansoprazole
Technical field
The present invention relates to the synthesis technique of a kind of proton pump inhibitor, be specifically related to the synthesis technique of a kind of lansoprazole.
Background technology
Because of the development of society, rhythm of life is accelerated, and the sickness rate of gastrointestinal disease also has the trend raised year by year, this type of disease Pharmaceutical market also by steady-state growth.
Lansoprazole is as a kind of novel proton pump inhibitor, and it is second novel proton pump after omeprazole exploitation Inhibitor, it is by acting on the H of parietal cell+-K+-ATP enzyme, makes the H of parietal cell+Can not be transported in stomach, with The gastric acid amount in gastric juice that causes is greatly reduced, thus gastric acid secretion inhibiting, to basal gastric acid secretion and by histamine, pentagastrin, The gastric acid that dibutyl cyclic AMP, choline and food etc. cause is formed has, with secretion, the inhibitory action that strength is lasting, and it suppresses to make With being substantially better than the effect protected to gastrointestinal mucosa simultaneously of H2 receptor blocking agent, burst for duodenal ulcer, stomach clinically Infections, reflux esophagitis, the treatment of Zuo-Chinese mugwort (Zollinger-Ellison) syndrome (gastrinoma), evident in efficacy, Helicobacter pylori is also had inhibitory action, therefore, the synthesis technique of lansoprazole is carried out in-depth study there is important meaning Justice.
The patent documentation (publication date is on 08 01st, 2012) of Publication No. CN102617555A discloses a kind of blue rope Draw the preparation method of azoles, comprise the following steps: by 2-chloromethyl-3-methyl-4-trifluoro ethoxy pyridine hydrochlorate and 2-sulfydryl -benzimidazole reacts [[[3-methyl-4-(2,2,2-trifluoro ethoxy)-pyridine-2-base] methyl] in sodium carbonate methanol solution Sulfenyl]-1H-benzimidazole, with the combination of cumyl hydroperoxide-tetraisopropyl titanate, aoxidize [[[3-methyl-4-(2,2, 2-trifluoro ethoxy)-pyridine-2-base] methyl] sulfenyl]-1H-benzimidazole, obtain lansoprazole crude product, last lansoprazole Crude product use mixed solvent in temperature less than purification under the conditions of 50 DEG C, concentrate, be dried, obtain lansoprazole.
Although the above-mentioned synthetic method that prior art discloses a kind of lansoprazole, it is possible to meet certain needs, but above-mentioned Preparation method still suffers from certain defect: such as, lansoprazole crude product final step purification, concentrate, be dried link Yield be 90%, total recovery only has about 70%, and yield is on the low side can affect industrial large-scale production and application.
Therefore, there is further improvement and optimize demand in the synthetic method for above-mentioned lansoprazole, this is also this technology One of study hotspot in field and emphasis, the present invention is accomplished especially power and starting point place.
Summary of the invention
For the technical problem that the lansoprazole total recovery overcoming prior art to exist is on the low side, the present inventor is being carried out in a large number Further investigation after, thus complete the present invention.
The present invention is achieved through the following technical solutions, the synthesis technique of a kind of lansoprazole, comprises the steps:
Step one, takes natrium carbonicum calcinatum and adds in absolute methanol, open stirring, add 2-chloromethyl-3-methyl-4-trifluoro second Epoxide pyridine hydrochloride and 2-mercapto-benzimidazole, be heated to 60-70 DEG C of reaction, stops heating and be cooled to room temperature after 2-4h, Filtering, filtrate reduced in volume, filter, filter cake absolute methanol washs, and filtrate is concentrated into no liquid and oozes, to residue Huang Adding toluene in color dope, stirring, to muddy, concentrates, room temperature crystallize, filters after 5-8h, and filter cake toluene washs, Obtain off-white color solid;
Step 2, takes toluene, ethyl acetate or dichloromethane and is heated to 26-30 DEG C, adds tetraisopropyl titanate, stirs, Add above-mentioned off-white color solid and water, continue 26-30 DEG C stir 15-25 minute, after be warming up to 54-56 DEG C reaction 1-1.5h, Stop heating, be cooled to 26-30 DEG C, add DIPEA or triethylamine, then drip cumene hydroperoxide, Continuing after adding to react 1-1.5h at 26-30 DEG C, then add ammonia in reactant liquor, separatory, organic facies extracts with ammonia again Taking, merge aqueous phase, be neutralized to pH6.5-7.5 with acetic acid, extract with dichloromethane, water layer extracts with dichloromethane again, closes And organic facies, organic facies is 0.05-0.08MPa in vacuum, temperature be 35-50 DEG C at reclaim organic solvent, then It is dried at 30-35 DEG C, obtains yellow solid;
Step 3, takes above-mentioned yellow solid and acetone mixing is complete, is heated to 52-56 DEG C, and insulated and stirred is to all Dissolving, heat filtering, heat filtering terminates, filtrate added drop-wise water, adds and is cooled to 5-15 DEG C, is incubated 2-3h, obtains white solid Body precipitate, filters, filter cake ice acetone drip washing, drains, be dried to constant weight, it is thus achieved that lansoprazole at 30-35 DEG C.
In described step 3, temperature range 52-56 DEG C of heat temperature raising includes and belongs to any concrete point value therein, Such as 52 DEG C, 53 DEG C, 54 DEG C, 55 DEG C, 56 DEG C, most preferably 54 DEG C, also include in these concrete point values is any The scope that two point values are constituted, more preferably 53~55 DEG C.
In described step one, temperature range 60-70 DEG C of heating includes and belongs to any concrete point value therein, such as 60 DEG C, 61 DEG C, 62 DEG C, 63 DEG C, 64 DEG C, 65 DEG C, 66 DEG C, 67 DEG C, 68 DEG C, 69 DEG C, 70 DEG C, most preferably 64 DEG C, Also include the scope that any two point value in these concrete point values is constituted, more preferably 62~65 DEG C.
Compared with prior art, beneficial effects of the present invention is as follows: emphasis of the present invention is by improving and in optimization step three Lansoprazole purifying crude condition so that the purification of final step, concentrate, be dried the yield of link by the 90% of prior art Bringing up to 98%, it is possible to significantly improve yield in final step, this is for making full use of the intermediate of prior step, raising Total recovery, reduces the large-scale production and application that cost is most important, the most industrial.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in detail.Following example will assist in those skilled in the art Member is further appreciated by the present invention, but limits the present invention the most in any form.It should be pointed out that, the common skill to this area For art personnel, without departing from the inventive concept of the premise, it is also possible to make some deformation and improvement.These broadly fall into Protection scope of the present invention.
Embodiment 1
The present embodiment relates to the synthesis technique of a kind of lansoprazole, comprises the steps:
Step one, takes 105.3g natrium carbonicum calcinatum and adds in 1.2L absolute methanol, open stirring, add 124.3g 2-chloromethane Base-3-methyl-4-trifluoro ethoxy pyridine hydrochlorate and 66.75g 2-mercapto-benzimidazole, add post-heating to 64 DEG C of reactions, Stop heating after 3h and be cooled to room temperature (25 DEG C), be filtered to remove insoluble matter, filtrate reduced in volume to about 200g, filters, filter Cake washs with a small amount of absolute methanol, and filtrate is concentrated into no liquid and oozes, and adds 200ml toluene in residue clear yellow viscous thing, Under room temperature (25 DEG C), stirring is to muddy, and solution decompression is concentrated into 251g, continues room temperature (25 DEG C) stirring and crystallizing, after 6h Filtering, filter cake 70ml toluene washs, and obtains 146.2g off-white color solid, yield 92%;
Step 2, takes 570ml toluene and is heated to 28 DEG C, adds 44.29g tetraisopropyl titanate, stirs 30 minutes, adds 118g above-mentioned off-white color solid and water, continue 28 DEG C stir 20 minutes, after be warming up to 55 DEG C reaction 1h, stop heating, It is cooled to 28 DEG C, adds 21.41g DIPEA, dropping 66.49ml 70% (mass percent concentration) Cumene hydroperoxide, continues after adding to react 1.2h at 28 DEG C, adds 570ml 12.5% after stopped reaction in reactant liquor The ammonia of (mass percent), separatory, organic facies is again with the ammonia of 2*570ml 12.5% (mass percent concentration) Extraction, merges aqueous phase, is neutralized to pH about 7.0 with 398.0ml acetic acid, extracts with 500ml dichloromethane, and water layer uses 2*250 again Ml dichloromethane extract, merge organic facies, organic facies is 0.06MPa in vacuum, temperature be reclaim at 45 DEG C organic molten Agent is to most, then is dried at 35 DEG C, obtains 112.3g yellow solid, yield 91%;
Step 3, at 500mL equipped with sealing stirring, reflux condensing tube, Dropping funnel and the clean four-necked bottle of thermometer In, adding above-mentioned 25g yellow solid and 125mL acetone, mixing completely, is heated to 54 DEG C, insulated and stirred 30min, Not dissolving minimizing, heat filtering to solid, heat filtering terminates, filtrate added drop-wise 75mL purified water, adds and is cooled to 10 DEG C, Insulation 2h, obtain white solid precipitates, filter, filter cake 24mL ice acetone drip washing, drain lansoprazole refine Wet product, is dried to constant weight at 32 DEG C, obtains lansoprazole fine work 21.9g, HPLC purity 99.89%, yield 98%.
1H-NMR(CDCl3, 500MHz) and δ: 11.84 (bs, 1H), 8.22 (d, J=5.7Hz, 1H), 7.64 (bs, 1H), 7.36 (bs, 1H), 7.21~7.16 (m, 2H), 6.53 (d, J=5.7Hz, 1H), 4.66 (q, 2H), 4.23-4.18 (m, 2H), 2.06 (s, 3H).
Embodiment 2
The present embodiment relates to the synthesis technique of a kind of lansoprazole, comprises the steps:
Step one, takes 105.3g natrium carbonicum calcinatum and adds in 1.2L absolute methanol, open stirring, add 124.3g 2-chlorine Methyl-3-methyl-4-trifluoro ethoxy pyridine hydrochlorate and 66.75g 2-mercapto-benzimidazole, add post-heating anti-to 60 DEG C Should, stop heating after 4h and be cooled to room temperature (25 DEG C), be filtered to remove insoluble matter, filtrate reduced in volume to about 200g, filter, Filter cake washs with a small amount of absolute methanol, and filtrate is concentrated into no liquid and oozes, and adds 200ml first in residue clear yellow viscous thing Benzene, under room temperature (25 DEG C), stirring is to muddy, and solution decompression is concentrated into 251g, continues room temperature (25 DEG C) stirring and crystallizing, and 5 Filtering after h, filter cake 70ml toluene washs, and obtains 146.1g off-white color solid, yield 91.9%;
Step 2, takes 570ml ethyl acetate and is heated to 29 DEG C, adds 44.29g tetraisopropyl titanate, stirs 30 minutes, Add 118g above-mentioned off-white color solid and water, continue 29 DEG C and stir 15 minutes, after be warming up to 56 DEG C and react 1.5h, stop adding Heat, is cooled to 29 DEG C, adds 21.41g triethylamine, drips 66.49ml 70% cumene hydroperoxide, continues after adding Reacting 1.5h at 29 DEG C, add the ammonia of 570ml 12.5% after stopped reaction in reactant liquor, separatory, organic facies is used again 2*570ml 12.5% ammonia extracts, and merges aqueous phase, is neutralized to pH about 7.5 with 398.0ml acetic acid, uses 500ml dichloromethane Alkane extracts, and water layer extracts with 2*250ml dichloromethane again, merges organic facies, and organic facies is 0.05MPa in vacuum, Temperature is that at 40 DEG C, recovery organic solvent is to most drier at 30 DEG C, obtains 112.5g yellow solid, yield 91.2%;
Step 3, at 500mL equipped with sealing stirring, reflux condensing tube, Dropping funnel and the clean four-necked bottle of thermometer In, adding above-mentioned 25g yellow solid and 125mL acetone, mixing completely, is heated to 55 DEG C, insulated and stirred 30min, Not dissolving minimizing, heat filtering to solid, heat filtering terminates, filtrate added drop-wise 75mL purified water, adds and is cooled to 5 DEG C, Insulation 3h, obtain white solid precipitates, filter, filter cake 24mL ice acetone drip washing, drain lansoprazole refine Wet product, is dried to constant weight at 34 DEG C, obtains lansoprazole fine work 21.8g, HPLC purity 99.86%, yield 97.6%.
1H-NMR(CDCl3, 500MHz) and δ: 11.82 (bs, 1H), 8.22 (d, J=5.7Hz, 1H), 7.63 (bs, 1H), 7.36 (bs, 1H), 7.20~7.15 (m, 2H), 6.53 (d, J=5.7Hz, 1H), 4.68 (q, 2H), 4.21-4.18 (m, 2H), 2.06 (s, 3H);
Embodiment 3
The present embodiment relates to the synthesis technique of a kind of lansoprazole, comprises the steps:
Step one, takes 105.3g natrium carbonicum calcinatum and adds in 1.2L absolute methanol, open stirring, add 124.3g 2-chloromethane Base-3-methyl-4-trifluoro ethoxy pyridine hydrochlorate and 66.75g 2-mercapto-benzimidazole, add post-heating to 62 DEG C of reactions, Stop heating after 2h and be cooled to room temperature (25 DEG C), be filtered to remove insoluble matter, filtrate reduced in volume to about 200g, filter, Filter cake washs with a small amount of absolute methanol, and filtrate is concentrated into no liquid and oozes, and adds 200ml first in residue clear yellow viscous thing Benzene, under room temperature (25 DEG C), stirring is to muddy, and solution decompression is concentrated into 251g, continues room temperature (25 DEG C) stirring and crystallizing, Filtering after 6h, filter cake 70ml toluene washs, and obtains 146.3g off-white color solid, yield 92.1%;
Step 2, takes 570ml dichloromethane and is heated to 30 DEG C, adds 44.29g tetraisopropyl titanate, stirs 30 minutes, Add 118g above-mentioned off-white color solid and water, continue 30 DEG C and stir 20 minutes, after be warming up to 54 DEG C and react 1h, stop adding Heat, is cooled to 30 DEG C, adds 21.41g DIPEA, drips 66.49ml 70% cumene hydroperoxide, Continue after adding 30 DEG C react 1.0h, after stopped reaction in reactant liquor add 570ml 12.5% ammonia, separatory, Organic facies with the 12.5% ammonia extraction of 2*570ml, merges aqueous phase, is neutralized to pH about 6.5 with 398.0ml acetic acid, use again 500ml dichloromethane extracts, and water layer extracts with 2*250ml dichloromethane again, merges organic facies, and organic facies is in vacuum For 0.08MPa, temperature is that at 50 DEG C, recovery organic solvent is to most drier at 32 DEG C, obtains 112.1g yellow solid, receives Rate 90.8%;
Step 3, at 500mL equipped with sealing stirring, reflux condensing tube, Dropping funnel and the clean four-necked bottle of thermometer In, adding above-mentioned 25g yellow solid and 125mL acetone, mixing completely, is heated to 56 DEG C, insulated and stirred 30min, Not dissolving minimizing, heat filtering to solid, heat filtering terminates, filtrate added drop-wise 75mL purified water, adds and is cooled to 15 DEG C, Insulation 2h, obtain white solid precipitates, filter, filter cake 24mL ice acetone drip washing, drain lansoprazole refine Wet product, is dried to constant weight at 30 DEG C, obtains lansoprazole fine work 21.7g, HPLC purity 99.85%, yield 97.1%.
1H-NMR(CDCl3, 500MHz) and δ: 11.83 (bs, 1H), 8.20 (d, J=5.7Hz, 1H), 7.61 (bs, 1H), 7.34 (bs, 1H), 7.21~7.15 (m, 2H), 6.53 (d, J=5.7Hz, 1H), 4.66 (q, 2H), 4.21-4.18 (m, 2H), 2.05 (s, 3H).
Embodiment 4
The present embodiment relates to the synthesis technique of a kind of lansoprazole, comprises the steps:
Step one, takes 105.3g natrium carbonicum calcinatum and adds in 1.2L absolute methanol, open stirring, add 124.3g 2-chloromethane Base-3-methyl-4-trifluoro ethoxy pyridine hydrochlorate and 66.75g 2-mercapto-benzimidazole, add post-heating to 70 DEG C of reactions, Stop heating after 3h and be cooled to room temperature (25 DEG C), be filtered to remove insoluble matter, filtrate reduced in volume to about 200g, filter, Filter cake washs with a small amount of absolute methanol, and filtrate is concentrated into no liquid and oozes, and adds 200ml first in residue clear yellow viscous thing Benzene, under room temperature (25 DEG C), stirring is to muddy, and solution decompression is concentrated into 251g, continues room temperature (25 DEG C) stirring and crystallizing, and 7 Filtering after h, filter cake 70ml toluene washs, and obtains 146.2g off-white color solid, yield 92.0%;
Step 2, takes 570ml toluene and is heated to 26 DEG C, adds 44.29g tetraisopropyl titanate, stirs 30 minutes, adds 118g above-mentioned off-white color solid and water, continue 26 DEG C stir 25 minutes, after be warming up to 55 DEG C reaction 1.5h, stop heating, It is cooled to 26 DEG C, adds 21.41g triethylamine, drip 66.49ml 70% cumene hydroperoxide, continue after adding at 26 DEG C Reaction 1.2h, adds the ammonia of 570ml 12.5% in reactant liquor after stopped reaction, separatory, organic facies uses 2*570ml again 12.5% ammonia extraction, merges aqueous phase, is neutralized to pH about 7.0 with 398.0ml acetic acid, then extracts with 500ml dichloromethane, Water layer extracts with 2*250ml dichloromethane again, merges organic facies, and organic facies is 0.07MPa in vacuum, and temperature is 35 DEG C Lower recovery organic solvent is to most, then is dried at 33 DEG C, obtains 112.0g yellow solid, yield 90.8%;
Step 3, at 500mL equipped with sealing stirring, reflux condensing tube, Dropping funnel and the clean four-necked bottle of thermometer In, adding above-mentioned 25g yellow solid and 125mL acetone, mixing completely, is heated to 52 DEG C, insulated and stirred 30min, Not dissolving minimizing, heat filtering to solid, heat filtering terminates, filtrate added drop-wise 75mL purified water, adds and is cooled to 10 DEG C, Insulation 3h, obtain white solid precipitates, filter, filter cake 24mL ice acetone drip washing, drain lansoprazole refine Wet product, is dried to constant weight at 33 DEG C, obtains lansoprazole fine work 21.6g, HPLC purity 99.87%, yield 96.7%.
1H-NMR(CDCl3, 500MHz) and δ: 11.83 (bs, 1H), 8.23 (d, J=5.7Hz, 1H), 7.63 (bs, 1H), 7.34 (bs, 1H), 7.18~7.15 (m, 2H), 6.53 (d, J=5.7Hz, 1H), 4.66 (q, 2H), 4.22-4.19 (m, 2H), 2.06 (s, 3H).
Embodiment 5
The present embodiment relates to the synthesis technique of a kind of lansoprazole, comprises the steps:
Step one, takes 105.3g natrium carbonicum calcinatum and adds in 1.2L absolute methanol, open stirring, add 124.3g 2-chloromethane Base-3-methyl-4-trifluoro ethoxy pyridine hydrochlorate and 66.75g 2-mercapto-benzimidazole, add post-heating to 65 DEG C of reactions, Stop heating after 4h and be cooled to room temperature (25 DEG C), be filtered to remove insoluble matter, filtrate reduced in volume to about 200g, filters, filter Cake washs with a small amount of absolute methanol, and filtrate is concentrated into no liquid and oozes, and adds 200ml toluene in residue clear yellow viscous thing, Under room temperature (25 DEG C), stirring is to muddy, and solution decompression is concentrated into 251g, continues room temperature (25 DEG C) stirring and crystallizing, after 8h Filtering, filter cake 70ml toluene washs, and obtains 146.0g off-white color solid, yield 91.9%;
Step 2, takes 570ml ethyl acetate and is heated to 28 DEG C, adds 44.29g tetraisopropyl titanate, stirs 30 minutes, Add 118g above-mentioned off-white color solid and water, continue 28 DEG C and stir 15 minutes, after be warming up to 56 DEG C and react 1h, stop adding Heat, is cooled to 28 DEG C, adds 21.41g DIPEA, drips 66.49ml 70% cumene hydroperoxide, Continue after adding 28 DEG C react 1.5h, after stopped reaction in reactant liquor add 570ml 12.5% ammonia, separatory, Organic facies extracts with 2*570ml 12.5% ammonia again, merges aqueous phase, is neutralized to pH about 7.5 with 398.0ml acetic acid, with 500 Ml dichloromethane extracts, and water layer extracts with 2*250ml dichloromethane again, merges organic facies, and organic facies is 0.06 in vacuum MPa, temperature is that at 50 DEG C, recovery organic solvent is to most drier at 34 DEG C, obtains 112.4g yellow solid, yield 91.1%;
Step 3, at 500mL equipped with sealing stirring, reflux condensing tube, Dropping funnel and the clean four-necked bottle of thermometer In, adding above-mentioned 25g yellow solid and 125mL acetone, mixing completely, is heated to 53 DEG C, insulated and stirred 30min, Not dissolving minimizing, heat filtering to solid, heat filtering terminates, filtrate added drop-wise 75mL purified water, adds and is cooled to 5 DEG C, Insulation 2h, obtain white solid precipitates, filter, filter cake 24mL ice acetone drip washing, drain lansoprazole refine Wet product, is dried to constant weight at 35 DEG C, obtains lansoprazole fine work 21.8g, HPLC purity 99.88%, yield 97.6%.
1H-NMR(CDCl3, 500MHz) and δ: 11.81 (bs, 1H), 8.20 (d, J=5.7Hz, 1H), 7.61 (bs, 1H), 7.34 (bs, 1H), 7.21~7.15 (m, 2H), 6.51 (d, J=5.7Hz, 1H), 4.66 (q, 2H), 4.22-4.18 (m, 2H), 2.05 (s, 3H).
Comparative example 1
In addition to the yellow solid in step 3 and acetone being mixed complete post-heating and is warming up to 38 DEG C, with the phase with embodiment 1 Comparative example 1 is implemented with mode, the lansoprazole fine work 20.2g that step 3 obtains, HPLC purity 99.3%, step The yield 90% of three.
1H-NMR(CDCl3, 500MHz) and δ: 11.83 (bs, 1H), 8.21 (d, J=5.7Hz, 1H), 7.62 (bs, 1H), 7.35 (bs, 1H), 7.20~7.15 (m, 2H), 6.52 (d, J=5.7Hz, 1H), 4.67 (q, 2H), 4.22-4.18 (m, 2H), 2.06 (s, 3H).
Comparative example 2
In addition to the yellow solid in step 3 and acetone being mixed complete post-heating and is warming up to 41 DEG C, with the phase with embodiment 1 Comparative example 2 is implemented with mode, the lansoprazole fine work 19.7g that step 3 obtains, HPLC purity 99.1%, step The yield 87.3% of three.
1H-NMR(CDCl3, 500MHz) and δ: 11.82 (bs, 1H), 8.20 (d, J=5.7Hz, 1H), 7.61 (bs, 1H), 7.34 (bs, 1H), 7.21~7.15 (m, 2H), 6.51 (d, J=5.7Hz, 1H), 4.66 (q, 2H), 4.23-4.18 (m, 2H), 2.05 (s, 3H).
Comparative example 3
In addition to the yellow solid in step 3 and acetone being mixed complete post-heating and is warming up to 45 DEG C, with the phase with embodiment 1 Comparative example 3 is implemented with mode, the lansoprazole fine work 20.1g that step 3 obtains, HPLC purity 98.9%, step The yield 89.1% of three.
1H-NMR(CDCl3, 500MHz) and δ: 11.82 (bs, 1H), 8.22 (d, J=5.7Hz, 1H), 7.63 (bs, 1H), 7.35 (bs, 1H), 7.20~7.16 (m, 2H), 6.54 (d, J=5.7Hz, 1H), 4.68 (q, 2H), 4.23-4.18 (m, 2H), 2.04 (s, 3H).
Comparative example 4
In addition to the yellow solid in step 3 and acetone being mixed complete post-heating and is warming up to 49 DEG C, with the phase with embodiment 1 Comparative example 4 is implemented with mode, the lansoprazole fine work 19.9g that step 3 obtains, HPLC purity 98.6%, step The yield 88.2% of three.
1H-NMR(CDCl3, 500MHz) and δ: 11.85 (bs, 1H), 8.20 (d, J=5.7Hz, 1H), 7.61 (bs, 1H), 7.36 (bs, 1H), 7.20~7.14 (m, 2H), 6.51 (d, J=5.7Hz, 1H), 4.68 (q, 2H), 4.23-4.18 (m, 2H), 2.02 (s, 3H).
Comparative example 5
In addition to the yellow solid in step 3 and acetone being mixed complete post-heating and is warming up to 35 DEG C, with the phase with embodiment 1 Comparative example 5 is implemented with mode, the lansoprazole fine work 20.0g that step 3 obtains, HPLC purity 99.1%, step The yield 88.7% of three.
1H-NMR(CDCl3, 500MHz) and δ: 11.81 (bs, 1H), 8.20 (d, J=5.7Hz, 1H), 7.61 (bs, 1H), 7.33 (bs, 1H), 7.22~7.15 (m, 2H), 6.53 (d, J=5.7Hz, 1H), 4.66 (q, 2H), 4.24-4.18 (m, 2H), 2.04 (s, 3H).
Implementation result
Implement above-described embodiment 1-5 and comparative example 1-5 respectively, and respectively according to the lansoprazole fine work pair obtained in step 3 The yield of step 3 is added up.In rapid three, when yellow solid and the acetone complete post-heating of mixing are warming up to 52-56 DEG C, In step 3, the yield of lansoprazole fine work is 96.7-98.0% (see embodiment 1-5), and when this temperature is less than 50 DEG C of conditions Time, in step 3, the yield of lansoprazole fine work is reduced to 88.7-90.0% (see comparative example 1-5), and the range of decrease is obvious, explanation Above-mentioned yellow solid and acetone mix temperature that complete post-heating heats up in step 3 lansoprazole fine work yield and Total recovery has appreciable impact.
Above the specific embodiment of the present invention is described.It is to be appreciated that the invention is not limited in above-mentioned spy Determining embodiment, those skilled in the art can make various deformation or amendment within the scope of the claims, this not shadow Ring the flesh and blood of the present invention.

Claims (1)

1. the synthesis technique of a lansoprazole, it is characterised in that comprise the steps:
Step one, takes natrium carbonicum calcinatum and adds in absolute methanol, open stirring, add 2-chloromethyl-3-methyl-4- Trifluoro ethoxy pyridine hydrochlorate and 2-mercapto-benzimidazole, be heated to 60-70 DEG C of reaction, stops adding after 2-4h Heat is cooled to room temperature, filters, filtrate reduced in volume, filters, and filter cake absolute methanol washs, and filtrate is concentrated into No liquid oozes, and adds toluene in residue clear yellow viscous thing, and stirring, to muddy, concentrates, room temperature crystallize, 5-8 Filtering after h, filter cake toluene washs, and obtains off-white color solid;
Step 2, takes toluene, ethyl acetate or dichloromethane and is heated to 26-30 DEG C, adds tetraisopropyl titanate, Stirring, add above-mentioned off-white color solid and water, continues 26-30 DEG C stirring 15-25 minute, after be warming up to 54-56 DEG C Reaction 1-1.5h, stops heating, is cooled to 26-30 DEG C, adds DIPEA or triethylamine, connects Dropping cumene hydroperoxide, continue after adding to react 1-1.5h at 26-30 DEG C, then add in reactant liquor Ammonia, separatory, organic facies extracts with ammonia again, merges aqueous phase, is neutralized to pH6.5-7.5 with acetic acid, uses dichloro Methane extracts, and water layer extracts with dichloromethane again, merges organic facies, and organic facies is 0.05-0.08 in vacuum MPa, temperature reclaims organic solvent, then is dried at 30-35 DEG C, obtains yellow solid at being 35-50 DEG C;
Step 3, takes above-mentioned yellow solid and acetone mixing is complete, is heated to 54 DEG C, and insulated and stirred is to entirely Portion dissolves, heat filtering, and heat filtering terminates, filtrate added drop-wise water, adds and is cooled to 5-15 DEG C, is incubated 2-3h, To white solid precipitates, filter, filter cake ice acetone drip washing, drain, be dried to constant weight at 30-35 DEG C, Obtain lansoprazole.
CN201410663797.3A 2014-11-19 2014-11-19 The synthesis technique of lansoprazole Active CN104447696B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410663797.3A CN104447696B (en) 2014-11-19 2014-11-19 The synthesis technique of lansoprazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410663797.3A CN104447696B (en) 2014-11-19 2014-11-19 The synthesis technique of lansoprazole

Publications (2)

Publication Number Publication Date
CN104447696A CN104447696A (en) 2015-03-25
CN104447696B true CN104447696B (en) 2016-08-17

Family

ID=52894520

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410663797.3A Active CN104447696B (en) 2014-11-19 2014-11-19 The synthesis technique of lansoprazole

Country Status (1)

Country Link
CN (1) CN104447696B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074952A1 (en) * 2005-01-14 2006-07-20 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
CN102267979A (en) * 2011-06-15 2011-12-07 扬州天和药业有限公司 Method for preparing lansoprazole
CN102617555A (en) * 2012-03-20 2012-08-01 西藏易明西雅生物医药科技有限公司 Preparation method of lansoprazole

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074952A1 (en) * 2005-01-14 2006-07-20 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing lansoprazole
CN102267979A (en) * 2011-06-15 2011-12-07 扬州天和药业有限公司 Method for preparing lansoprazole
CN102617555A (en) * 2012-03-20 2012-08-01 西藏易明西雅生物医药科技有限公司 Preparation method of lansoprazole

Also Published As

Publication number Publication date
CN104447696A (en) 2015-03-25

Similar Documents

Publication Publication Date Title
CN102617555B (en) Preparation method of lansoprazole
CN106187852B (en) A kind of preparation method of Vonoprazan fumarate intermediate
CN105732622B (en) A kind of preparation method of Eliquis
CN101475562B (en) Method for synthesizing lansoprazole and salt thereof
CN103232438B (en) Pantoprazole sodium and preparation method thereof
CN105130955B (en) The preparation method of Vonoprazan fumarate
CN103044402A (en) Method for synthesizing esomeprazole sodium
CN106928191B (en) A kind of preparation process of Lansoprazole
CN112707889B (en) Synthesis method of lansoprazole
CN104447696B (en) The synthesis technique of lansoprazole
CN104650039A (en) Preparation method of ilaprazole
CN104311485B (en) A kind of preparation method treating leukemic medicine bosutinib
CN106977512B (en) The method for preparing the smooth free alkali of horse sieve
CN101279987A (en) Production process of tenofovir
CN110483498B (en) Preparation method of tazobactam intermediate
CN104530006B (en) The preparation method of Lansoprazole
CN106892863A (en) The preparation method of vismodegib and its intermediate
CN101712480A (en) Method for preparing anhydrous sodium carbonate
CN108947967B (en) Preparation method of lansoprazole
CN108250184A (en) A kind of intermediate of Topiroxostat and preparation method thereof and the method that Topiroxostat is prepared by the intermediate
CN102267979A (en) Method for preparing lansoprazole
CN103664885A (en) Preparation method of benzimidazole proton pump inhibitor intermediate
CN101531633B (en) Purification method of quinaldine
CN103570681A (en) Prepration method of esomeprazole key intermediate
CN105481833B (en) A kind of preparation method of Rupatadine fumarate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant